Literature DB >> 15601439

Volumes of distribution.

P L Toutain1, A Bousquet-Mélou.   

Abstract

Volumes of distribution are proportionality constants between total amount of drug in the body and plasma concentrations. As snapshot plasma drug concentrations may be measured in different conditions (at equilibrium, under pseudo-equilibrium condition,...), several volumes of distribution have been defined. The two most relevant are the volume of distribution at equilibrium (V(ss)), and the volume of distribution during pseudo-equilibrium (V(area)). Volumes of distribution are used to compute a loading dose (V(ss)) or the residual amount of drug in the body knowing plasma concentrations (V(area)). Volume of distribution may be interpreted in terms of drug distribution having recourse to physiological models involving drug binding to plasma and tissues. Volumes of distribution should be determined early in drug development programmes and those having a large volume of distribution may be selected to obtain a long terminal half-life even for drugs having a relatively high clearance.

Mesh:

Substances:

Year:  2004        PMID: 15601439     DOI: 10.1111/j.1365-2885.2004.00602.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  28 in total

1.  Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.

Authors:  Barent DuBois; Samantha Louey; George D Giraud; Ganesh Cherala; Sonnet S Jonker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-03-19       Impact factor: 4.080

Review 2.  A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.

Authors:  Valentina Pistolesi; Santo Morabito; Francesca Di Mario; Giuseppe Regolisti; Chiara Cantarelli; Enrico Fiaccadori
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).

Authors:  Robert Papp; Aleksandar Popovic; Nancy Kelly; Richard Tschirret-Guth
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

4.  Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-07-12       Impact factor: 2.745

5.  Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers.

Authors:  Max Taubert; Joseph Chiesa; Mark Lückermann; Carsten Fischer; Axel Dalhoff; Uwe Fuhr
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  An Expandable Mechanopharmaceutical Device (1): Measuring the Cargo Capacity of Macrophages in a Living Organism.

Authors:  Phillip Rzeczycki; Tehetina Woldemichael; Andrew Willmer; Mikhail D Murashov; Jason Baik; Rahul Keswani; Gi Sang Yoon; Kathleen A Stringer; Nair Rodriguez-Hornedo; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-12       Impact factor: 4.200

7.  Nicotine pharmacokinetics in rats is altered as a function of age, impacting the interpretation of animal model data.

Authors:  Evelyn L Craig; Bin Zhao; Jason Z Cui; Maria Novalen; Sharon Miksys; Rachel F Tyndale
Journal:  Drug Metab Dispos       Date:  2014-06-30       Impact factor: 3.922

8.  Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL/6 mice.

Authors:  Joelle C Ingrao; Ron Johnson; Elizabeth Tor; Yu Gu; Marcus Litman; Patricia V Turner
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

9.  Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration.

Authors:  Ayman Goudah; Sherifa Hasabelnaby
Journal:  Vet Med Int       Date:  2010-11-02

10.  A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients.

Authors:  Alain Bousquet-Mélou; Anne Lespine; Jean-François Sutra; Isabelle Bargues; Pierre-Louis Toutain
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.